Akari Therapeutics Issues 2025 End of Year Letter to Shareholders
December 30, 2025 09:15 ET | Source: Akari Therapeutics Plc TAMPA, Fla.…
AlphaTON Capital Corp Issues Clarification on Anduril Industries Investment Program
DOVER, DE, Dec. 17, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (NASDAQ:…
14th Olympic Summit on 11 December 2025 Information for the media
05 December 2025 - The International Olympic Committee (IOC) will host the 14th…
Cribl Supercharges Incident Response in Amazon Security Hub with Open Cybersecurity Schema Framework (OCSF) Support
Enhanced capability in Cribl Stream transforms disparate security findings into a standardized…
vHive Launches Real-Time Solution to Validate As-Built Installations for MNOs
NEW YORK, Dec. 2, 2025 /PRNewswire/ -- vHive, a global leader in infrastructure…
NABR: CITES Standing Committee Issues Assessment of Long-Tailed Macaque Monkey Breeding Practices
WASHINGTON, Nov. 19, 2025 /PRNewswire/ -- The Standing Committee of CITES, an…
IOC and Samsung celebrate Solve for Tomorrow, Sport & Tech winners in Milan
05 November 2025 - Five outstanding teams were celebrated in Milan on…
Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business
COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the…
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed…
CORRECTION Algae-C Acquisition by Rockcliffe Labs
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Algae-C Inc. (“Algae-C”) today issues…